medigraphic.com
ISSN 1561-2988 (Print)

2011, Number 4

<< Back Next >>

Rev Cubana Farm 2011; 45 (4)

Effect of Phyllanthus orbicularis on the cell viability and the hepatitis B surface antigen in PLC/PRF/5 cells

Roque QA, Salazar GI, Morier DL, del Barrio AG

Language: Spanish
References: 29
Page: 536-544
PDF size: 60.54 Kb.


ABSTRACT

The antiviral activity of Phyllanthus orbicularis, an endemic Cuban plant, against the hepatitis B virus was evaluated in vitro. The ability of the aqueous extract and 2 tannin- and flavonoid-rich chemical fractions (aqueous-acetic and buthanolic) to inhibit the hepatitis B surface antigen (HBsAg) production was determined in PLF/PRC/5 cellas, a human hepatoma cell line that constitutively expresses this antigen. The aqueous extract was effective in inhibiting the HBsAg at 24 and 48 hours of treatment, being the selective index (SI) above 10, with concentration-dependent inhibitory activity. The evaluation of the inhibitory action of the two fractions from the plant proved that both were effective and their selective indexes were also higher than 10. These results indicated the inhibitory activity against HBsAg of the plant and the presence of phenolic compounds that could reduce the antigen production. This may contribute to an in vivo antiviral action. This paper also corroborated the antiviral potential of the aqueous extract from Phyllanthus orbicularis Kunth, in addition to supporting the use of PLC/PRF/5 for future evaluations or trials directed towards assessing the anti-hepatitis B activity of various products. Likewise, it paved the way for the detection of the chemical component(s) responsible for the plant's action against hepatitis B virus.


REFERENCES

  1. Ganem, D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 2004;350: 1118-29.

  2. La, CL, Ratziu V, Yuen MF, Poinard T. Viral Hepatitis B. Lancet. 2003;362:2089-94.

  3. Zoulim F. Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Antiv Res. 1999;44:1-30.

  4. Unander DW, Webster GL, Blumberg BS. Usage and bioassay in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral use and the other effects. J Ethnopharmacol. 1995;45:1-18.

  5. del Barrio G, Caballero O, Rivas L, García D. Efecto de extractos de Phyllanthus orbicularis sobre el AgsHB del virus de la hepatitis B. Avances en Biotecnología Moderna. 1994;2:236.

  6. del Barrio G, Roque A. Inactivación del HBsAg por un extracto de Phyllanthus orbicularis. Rev Cubana Plantas Med. 1999;3:95-7.

  7. del Barrio G, Parra F. Evaluation of the antiviral activity of an aqueous extract from Phyllanthus orbicularis. J Ethnopharmacol. 2000;72:317-22.

  8. Fernández JA, del Barrio G, Romeu B, Gutiérrez Y, Valdés S, Parra F. In vitro antiviral activity of Phyllanthus orbicularis extracts against herpes simplex virus type 1. Phytotherapy Res. 2003;17:980-2.

  9. Álvarez A, del Barrio G, Kourí V, Álvarez PA, Suárez B, Parra, F. In vitro antiherpetic activity of an aqueous extract from the plant Phyllanthus orbicularis. Phytomedicine. 2009;16:960-6.

  10. Gutiérrez Gaitén YI, Miranda Martínez M, Hernández Sánchez T, del Barrio G. Estudio de algunos fitoconstituyentes de Phyllanthus orbicularis HBK. Rev Cubana Farm. 2000;34:299-300.

  11. Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and citotoxicity assay. J Immunol Meth. 1983;65:55-63.

  12. Gonzalez Griego A. Método de cuantificación del HBsAg. Rev. Cubana Invest Biomed. 1991;10:156-9.

  13. Alexander JJ, Bey EM, Geddes EW, Lecatsar G. Establishment of a continuously growing cell line from primary carcinoma of the lives. S Afr Med J. 1976;50:2124-5.

  14. Ji XH, Qin YZ, Wang WY, Zhu JY, Liu XT. Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line. Chung Kuo Chung Yao Tsa Chih. 1993; 18:496-8.

  15. Jayaram S, Thyagarajan SP. Inhibition of the HBsAg secretion from Alexander cell line by Phyllanthus. amarus. Indian J Pathol Microbiol. 1996;39:211-5.

  16. Gutiérrez YI, Miranda M, Henríquez AT, y del Barrio G. Análisis de flavonoides en una fracción butanólica obtenida de Phyllanthus orbicularis HBK. Rev Cubana Farm. 2010;44(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152010000300011&lng=es&nrm=iso

  17. Álvarez AL, Diñeiro Y, del Barrio G, Picinelli A, Suárez B, Valdés S, et al. Bioactivity-guided separation of anti HSV-2 and antioxidant metabolites from the plant Phyllanthus orbicularis. Planta Medica. 2009;75:990.

  18. Calixto JB, Santos AR, Pihlo UC, Vanes RA. Review of the plant of the genus Phyllanthus: Their chemistry, pharmacology and therapeutic potential. Med Res.Rev. 1998;18:225- 58.

  19. Li J, Huang H, Zhou W, Feng M, Zhou P. Anti-hepatitis B Virus Activities of Geranium carolinianum L. Extracts and Identification of the Active Components. Biol Pharm Bull. 2008;31(4):743-7.

  20. Notka F, Meier G, Wagner R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res. 2004;64:93-102.

  21. Yu D, Morris-Natschke SL, Lee KH. New Developments in Natural Products-Based Anti-AIDS Research. Med Res Rev. 2007;27(1):108-32.

  22. Zhang J, Zhang B, Yao X, Gao Y, Shong J. Antiviral activity of tannin from the pericarp of Punica granatum, L. against genital herpesvirus in vitro. Chung Kuo Chung Yao Tsa Chih. 1995;20:556-8.

  23. Zuo G, Li Z, Chen L, Xu X. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease. Antiviral Res. 2007;76:86-92.

  24. Vailati A, Aristia L, Sozze E. Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. Fitoterapia. 1993;64:219-27.

  25. Suzuki H, Ohta Y, Takino T. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis. Double blind trial. Asian Med J. 1983;26:423-38.

  26. Zembower DE, Lin YM, Flavin MT, Chen FC, Korba BE. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiv Res. 1998;39:81-8.

  27. Kim KH, Kim YH, Lee KR. Isolation of quinic acid derivatives and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro. Bioorg Med Chem Lett. 2007;17(24):6739-43.

  28. Yang G, Chen D. Biflavonones, flavonoids, and coumarins from the roots of Stellera chamaesjasme and their antiviral effect on HBV. Chem Biodivers. 2008;5(7):1419-24.

  29. Sánchez-Lamar A, Fuentes JL, Fonseca G, Capiro N, Ferrer M, Alonzo A, et al. Assessment of the potential genotoxic risk of Phyllantus orbicularis HBK aqueous extract using in vitro and in vivo assays. Toxicol Lett. 2002;136(2):87-96.




2020     |     www.medigraphic.com